| Summary: | 碩士 === 南臺科技大學 === 企業管理系 === 103 === The transradial artery approach has become the popular treatment of coronary artery due to technical advance of coronary intervention. This technique is associated with fewer vascular access complications and has been shown some advantages, such as easy-to-stop bleeding, rapid postoperative recovery, and no impact on the application of anticoagulant drugs.
Therefore, it is worth to explore and seek a more secure, reliable, and easy hemostatic method for the coronary intervention. This study aims to investigate the safety and efficacy of a novel hemostatic device for the transradial artery approach. We adopted a prospective approach and selected 230 cases with positive Allen's test results to investigate efficacy of the novel hemostatic device. The eligible cases were randomly assigned into experimental group and control group according to the aspiration of the patients. We employed the novel hemostatic device for the experimental group and conventional hemostatic bandage for the control group, and then collected related postoperative hemostasis results which include oxygen saturation on oppression side finger, pain degrees of patients’ feeling, and hemostasis complication rate, to analyze efficacy of the novel hemostatic device.
The analysis results of this study showed that the experimental group with novel hemostatic device has better results on the degrees of pain and hemostasis complication rate than the control group with hemostatic bandage does. However, there is no significant difference in oxygen saturation on oppression side finger, stop bleeding time and stop bleeding effect between the two groups. According to the results of this study, the novel hemostatic device has not only the advantage in easy-to-operate and reduction of complications and pain, but also is a safe and effective way to achieved hemostasis when patient undergoing the treatment of coronary artery.
|
|---|
